Sudden Cardiac Arrest (SCA) is a life-threatening condition affecting hundreds of thousands of individuals each year, particularly those with low Left Ventricular Ejection Fraction (LVEF). While wearable cardioverter defibrillators (WCDs) are a well-established therapy for preventing SCA, adherence rates are often low. Kestra Medical Technologies is tackling this issue with [...]
Kestra Medical Technologies Ltd., a prominent name in the wearable medical devices sector, has officially filed for an initial public offering (IPO), showcasing a remarkable surge in revenue that has nearly tripled. The Bloomberg report highlights that the company is poised to offer new shares as part of this financial [...]
The financing secured will drive growth and accelerate commercial expansion efforts, support the scaling of commercial teams and outreach initiatives to bring CeQur Simplicity™, its 4-day wearable insulin delivery device, to more healthcare providers and patients managing diabetes. Horw, Switzerland, January 7, 2025 – CeQur®, a medical device company dedicated [...]
In the United States alone, an estimated 10-12 million adults live with moderate to severe chronic neuropathic pain. The effects can be debilitating, leading not only to extreme physical discomfort, but also psychological distress, social isolation, reduced worker productivity and an overall decrease in quality of life. [...]
SALT LAKE CITY, Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Lumeon Limited ("Lumeon"), a digital health company with operations in the U.S. [...]
KIRKLAND, Wash. July 24, 2024 08:00 AM Eastern Daylight--(BUSINESS WIRE)-- Kestra Medical Technologies, Inc., a privately held wearable medical device and digital healthcare company, today announced an oversubscribed $196 million funding round to support the expansion of their commercial organization and advance its mission of protecting at-risk patients with [...]
The CeQur Simplicity patch is now FDA-cleared for up to 4 days of wear. Each patch replaces up to 12 injections further simplifying mealtime insulin management. Horw, Switzerland, June 18, 2024 - CeQur®, a medical device company dedicated to simplifying insulin delivery for individuals on multiple daily injections, announces [...]
WESTBOROUGH, Massachusetts – April 2, 2024 – Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced closing of a $20 million Series B extension financing round. The funds will support commercial [...]
Following the welcome announcement that Virtual Incision has received FDA marketing authorization for MIRA, we spoke to Fernando Pacheco, investment director at Endeavour Vision, and board director at Virtual Incision to understand what the breakthrough will mean for healthcare providers, surgeons and patients alike… Let’s start with [...]
New category challenges industry standards in soft tissue robotic-assisted surgery and has the potential to expand access to minimally invasive care De Novo premarket review pathway establishes initial indication for adults undergoing colectomy procedures and lays the foundation for expansion into other abdominal procedures LINCOLN, Neb. – February [...]